Physician profile
James B Deville
NPI 1184677841
$171,167.87
in general payments reported to CMS, 2019-2025
24 companies · $16K in 2025
The $16K reported for 2025 was more than what 87% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $12K · 2021: $31K · 2022: $39K · 2023: $24K · 2024: $26K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $37K · Travel and Lodging: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,650 · Food and Beverage: $4,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $37,350.00 |
| Travel and Lodging | $17,380.42 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,650.00 |
| Food and Beverage | $4,345.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $78,516.39 | 2019-2025 | Carto 3, Thermocool Sf, Qdot Micro |
| Medical Device Business Services, INC. | $48,765.51 | 2019-2024 | Carto 3 |
| Boston Scientific Corporation | $28,896.21 | 2019-2025 | General - Therapies, Rhythmia Mapping System, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $11,325.46 | 2021-2025 | Affera Mapping System, Cobalt Dr Mri Surescan, Arctic Front Advance |
| Abbott Laboratories | $1,873.39 | 2021-2025 | Aveir, Ensite, Amplatzer Amulet |
| Itamar Medical INC | $505.55 | 2022-2024 | Watchpatone |
| Ebr Systems, INC. | $222.45 | 2025 | |
| Medtronic Vascular, INC. | $219.03 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $163.31 | 2019-2023 | Lifevest |
| Atricure, INC. | $143.18 | 2024 | |
| Impulse Dynamics (USA) INC. | $138.03 | 2023 | Optimizer |
| Zoll Respicardia, INC. | $98.84 | 2023 | Remede System |
| Janssen Pharmaceuticals, INC | $51.97 | 2019-2020 | |
| Irhythm Technologies, INC. | $46.04 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Baxter Healthcare | $42.99 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Altathera Pharmaceuticals LLC | $34.18 | 2024 | Sotalol Hydrochloride |
| E.R. Squibb & Sons, L.L.C. | $27.48 | 2019-2023 | Camzyos |
| Cordis US Corp. | $22.25 | 2025 | Mynx Control Venous |
| Sanofi-Aventis U.S. LLC | $18.91 | 2023 | |
| Vifor Pharma, INC. | $17.30 | 2021 | |
| Abiomed | $14.49 | 2019 | |
| Elutia, INC. | $13.86 | 2019 | |
| Pfizer INC. | $11.05 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Deville listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.